07th November 2025 The Central Drugs Standard Control Organisation (CDSCO) has issued a directive to all State Licensing Authorities (SLAs) to conduct inspections of pharmaceutical manufacturing firms in accordance with the Revised Schedule M requirements. As per the notice…
07th September, 2025 The Central Drugs Standard Control Organization (CDSCO) has released an important regulatory update regarding the approval process for combi-pack products—specifically combinations of lyophilized powders for injection or IV infusion with diluents like Sterile Water for Injection (SWFI)…
13th September,2025 The Government of India has just announced a significant change that will impact the pharmaceutical and medical devices industry, effective “22nd September 2025”. Yes, you read that right—GST rates on drugs, formulations, and medical devices are being reduced,…
5th August, 2025 The Ministry of Health and Family Welfare has issued G.S.R. 513(E) dated 29th July 2025, announcing pivotal amendments to the Cosmetics Rules, 2020 under the Drugs and Cosmetics Act, 1940. These changes aim to strengthen the regulatory…
9th July, 2025 🔍 Introduction In a significant move toward the digitization of drug regulatory processes in India, the Central Drugs Standard Control Organization (CDSCO), in collaboration with the Centre for Development of Advanced Computing (CDAC), has introduced a major…
Recent Post
- India Cracks Down on Chloramphenicol & Nitrofurans in Food Producing Animals
- CDSCO Directs All Drug Manufacturers to Establish Pharmacovigilance Systems Under Schedule M
- India brings Pregabalin under Schedule H1
- CDSCO Issues Stern Warning Against Injectable Cosmetics and Misleading Beauty Claims
- CDSCO Orders Nationwide Crackdown on Unauthorised GLP-1 Weight Loss Drugs
